Comments on: A Randomized Double-Blind Phase IIA Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)

Comments on: A Randomized Double-Blind Phase IIA Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD) https://scdstudies.com/a-randomized-double-blind-phase-iia-study-evaluating-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-crovalimab-as-adjunct-treatment-in-prevention-of-vaso-occlusive-episodes-voe-in-s/?utm_source=rss&utm_medium=rss&utm_campaign=a-randomized-double-blind-phase-iia-study-evaluating-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-crovalimab-as-adjunct-treatment-in-prevention-of-vaso-occlusive-episodes-voe-in-s Sat, 22 Jun 2024 12:17:15 +0000 hourly 1 https://wordpress.org/?v=6.7.1